First Manhattan’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-250
Closed -$20K 1506
2016
Q4
$20K Hold
250
﹤0.01% 1075
2016
Q3
$19K Sell
250
-67
-21% -$5.41K ﹤0.01% 1096
2016
Q2
$24K Sell
317
-58
-15% -$4.14K ﹤0.01% 1075
2016
Q1
$20K Sell
375
-995
-73% -$54.2K ﹤0.01% 1066
2015
Q4
$84K Hold
1,370
﹤0.01% 847
2015
Q3
$86K Hold
1,370
﹤0.01% 838
2015
Q2
$100K Sell
1,370
-175
-11% -$12.6K ﹤0.01% 825
2015
Q1
$101K Hold
1,545
﹤0.01% 827
2014
Q4
$100K Buy
1,545
+525
+51% +$33.8K ﹤0.01% 837
2014
Q3
$61K Hold
1,020
﹤0.01% 920
2014
Q2
$70K Hold
1,020
﹤0.01% 886
2014
Q1
$66K Hold
1,020
﹤0.01% 893
2013
Q4
$63K Hold
1,020
﹤0.01% 891
2013
Q3
$54K Sell
1,020
-3,610
-78% -$186K ﹤0.01% 915
2013
Q2
$241K Buy
+4,630
New +$201K ﹤0.01% 632

Other funds holding STJ

First Manhattan's STJ Position: Q1 2017 in Review

First Manhattan sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 250 shares — an estimated $20K sold.

First Manhattan first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $241K in Q2 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • First Manhattan reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • First Manhattan sold 250 St Jude Medical shares in Q1 2017, an estimated $20K.
  • First Manhattan first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • First Manhattan's St Jude Medical position peaked at $241K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on First Manhattan's 13F filing for Q1 2017, filed 24 Apr 2017.